ACTG ACACIA RESEARCH CORP
Patent Owners & Lessors · Nasdaq · SEC CIK 934549 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-3.7%
TTM net income YoY-468.9%
TTM EPS YoY-416.7%
Revenue 3-yr CAGR81.2%
Net income 3-yr CAGR—
Margins
Gross margin23.2%
Operating margin-6.0%
Net margin-6.5%
FCF margin—
EBITDA margin5.7%
Returns
ROE-3.4%
ROA-2.4%
ROIC (approx.)-4.9%
Asset turnover0.36x
Leverage & solvency
Liabilities / assets26.1%
Debt / equity0.21x
Current ratio5.64x
Interest coverage-2.17x
Cash quality & payout
Operating cash flow / net income-1.99x
Accruals ratio-7.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $285.23M | $122.31M |
| Cost of revenue | $200.75M | $92.66M |
| Gross profit | $84.48M | $29.65M |
| SG&A expense | $65.12M | $55.36M |
| Operating income | $6.41M | -$32.93M |
| Interest expense | $8.99M | $6.46M |
| Pretax income | $31.31M | -$38.15M |
| Income tax | $6.84M | -$3.45M |
| Net income | $21.68M | -$36.06M |
| EBITDA | $49.76M | $648,000 |
| EPS (basic) | 0.23 | -0.36 |
| EPS (diluted) | 0.22 | -0.36 |
| Weighted avg. shares (diluted) | 97.16M | 99.21M |
| Balance sheet | ||
| Cash & equivalents | $306.72M | $273.88M |
| Receivables | $26.16M | $26.91M |
| Inventory | $26.56M | $27.48M |
| Current assets | $450.09M | $420.15M |
| PP&E, net | $21.29M | $23.86M |
| Goodwill | $25.79M | $29.34M |
| Intangibles | $48.15M | $55.43M |
| Total assets | $770.96M | $756.39M |
| Current liabilities | $49.04M | $49.64M |
| Short-term debt | $0 | $2.40M |
| Long-term debt | $91.90M | — |
| Total debt | $91.90M | — |
| Total liabilities | $186.92M | $203.78M |
| Shareholders' equity | $543.45M | $514.83M |
| Net debt | -$214.82M | — |
| Shares outstanding | 96.48M | 96.05M |
| Cash flow statement | ||
| Operating cash flow | $75.24M | $50.12M |
| Capital expenditure | — | $148.67M |
| Free cash flow | — | -$98.55M |
| Investing cash flow | -$21.01M | -$212.96M |
| Financing cash flow | -$22.73M | $97.56M |
| Depreciation & amortization | $43.35M | $33.57M |
| Stock-based compensation | $5.74M | $4.79M |
| Dividends paid | — | $0 |
| Share buybacks | $0 | $20.29M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.